Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000947329> ?p ?o ?g. }
- W2000947329 endingPage "603" @default.
- W2000947329 startingPage "573" @default.
- W2000947329 abstract "Proarrhythmia, the development of new or worse arrhythmias in response to drug therapy, is a major limitation to the development and use of new drugs. There are different types of drug-induced proarrhythmia, including long-QT syndrome (LQTS), short-QT syndrome and proarrhythmia related to Na+-channel blockade/conduction impairment. By far the most important form of proarrhythmia at present is drug-induced LQTS and its associated characteristic tachyarrhythmia, torsades de pointes (TdP). TdP arises when cellular action potentials (APs) are excessively prolonged, leading to arrhyth-mogenic afterdepolarizations, especially early afterdepolarizations (EADs), which trigger complex re-entry in a substrate involving increased transmural dispersion of repolarization. In vitro screening, increasingly involving high-throughput assays, is used to assess potential candidate molecules and eliminate potentially problematic structures at an early stage of development. The most commonly used screening assays assess drug block of the K+ current carried by human ether-à-go-go (hERG) subunits, corresponding to the rapid delayed-rectifier K+ channel, the overwhelmingly most common target of TdP-inducing drugs. In addition, the effects of drugs on AP duration or the in vivo equivalent, QT interval, are often assessed in animal models. Methods available for repolarization-related proarrhythmic risk assessment include in vitro (Langendorff-perfused rabbit or guinea pig hearts) and in vivo models (such as α-adrenoceptor-stimulated rabbits, rabbits with reduced repolarization reserve due to block of slow delayed-rectifier current, animals with chronic atrioventricular block or animals with cardiac remodelling caused by congestive heart failure). In silico modelling may be helpful for molecular design of non-hERG blocking candidates and for optimization of compound selection (at the molecular and pharmacological profile levels). Finally, clinical evaluation of effects on electrocardiographic intervals (particularly QT) and cardiac rhythm are often needed, both prior to drug approval and after successful introduction on the market (postmarketing surveillance). The successful avoidance of proarrhythmic complications is a shared responsibility of the innovative pharmaceutical industry, regulatory authorities, partners in the clinical drug development phase and practicing physicians. This paper reviews the principal forms of proarrhythmia and the methods that can be used to minimize the risk of proarrhythmia in drug development and clinical practice, with particular emphasis on the most common and problematic form, acquired LQTS." @default.
- W2000947329 created "2016-06-24" @default.
- W2000947329 creator A5022641789 @default.
- W2000947329 creator A5064311226 @default.
- W2000947329 date "2010-03-01" @default.
- W2000947329 modified "2023-10-16" @default.
- W2000947329 title "Minimizing Repolarization-Related Proarrhythmic Risk in Drug Development and Clinical Practice" @default.
- W2000947329 cites W1480072903 @default.
- W2000947329 cites W1518380536 @default.
- W2000947329 cites W1530248218 @default.
- W2000947329 cites W1575021701 @default.
- W2000947329 cites W1590342525 @default.
- W2000947329 cites W1604250740 @default.
- W2000947329 cites W1837027726 @default.
- W2000947329 cites W184895251 @default.
- W2000947329 cites W1896290033 @default.
- W2000947329 cites W1927870581 @default.
- W2000947329 cites W1963748793 @default.
- W2000947329 cites W1963984359 @default.
- W2000947329 cites W1964047030 @default.
- W2000947329 cites W1964284576 @default.
- W2000947329 cites W1964454742 @default.
- W2000947329 cites W1964897845 @default.
- W2000947329 cites W1965523675 @default.
- W2000947329 cites W1967518576 @default.
- W2000947329 cites W1967747901 @default.
- W2000947329 cites W1967926730 @default.
- W2000947329 cites W1968098810 @default.
- W2000947329 cites W1968371524 @default.
- W2000947329 cites W1970214301 @default.
- W2000947329 cites W1970757917 @default.
- W2000947329 cites W1971268840 @default.
- W2000947329 cites W1972129740 @default.
- W2000947329 cites W1972280475 @default.
- W2000947329 cites W1972334317 @default.
- W2000947329 cites W1972489499 @default.
- W2000947329 cites W1973418403 @default.
- W2000947329 cites W1973496158 @default.
- W2000947329 cites W1974305002 @default.
- W2000947329 cites W1975596528 @default.
- W2000947329 cites W1975616941 @default.
- W2000947329 cites W1979365920 @default.
- W2000947329 cites W1979463298 @default.
- W2000947329 cites W1981464354 @default.
- W2000947329 cites W1982335452 @default.
- W2000947329 cites W1982459320 @default.
- W2000947329 cites W1982720702 @default.
- W2000947329 cites W1983199142 @default.
- W2000947329 cites W1983567286 @default.
- W2000947329 cites W1984313043 @default.
- W2000947329 cites W1984462595 @default.
- W2000947329 cites W1985459453 @default.
- W2000947329 cites W1985912434 @default.
- W2000947329 cites W1985988199 @default.
- W2000947329 cites W1988029425 @default.
- W2000947329 cites W1988595876 @default.
- W2000947329 cites W1989021629 @default.
- W2000947329 cites W1989558090 @default.
- W2000947329 cites W1990056867 @default.
- W2000947329 cites W1990111162 @default.
- W2000947329 cites W1991014832 @default.
- W2000947329 cites W1991492314 @default.
- W2000947329 cites W1993588163 @default.
- W2000947329 cites W1994502254 @default.
- W2000947329 cites W1994545844 @default.
- W2000947329 cites W1995033447 @default.
- W2000947329 cites W1995849691 @default.
- W2000947329 cites W1996802734 @default.
- W2000947329 cites W1997359529 @default.
- W2000947329 cites W1997946428 @default.
- W2000947329 cites W1998450521 @default.
- W2000947329 cites W2001338198 @default.
- W2000947329 cites W2001621576 @default.
- W2000947329 cites W2002314174 @default.
- W2000947329 cites W2003084475 @default.
- W2000947329 cites W2003149440 @default.
- W2000947329 cites W2004470604 @default.
- W2000947329 cites W2005391855 @default.
- W2000947329 cites W2005411701 @default.
- W2000947329 cites W2006060163 @default.
- W2000947329 cites W2006214313 @default.
- W2000947329 cites W2006337419 @default.
- W2000947329 cites W2006954736 @default.
- W2000947329 cites W2007312710 @default.
- W2000947329 cites W2007424446 @default.
- W2000947329 cites W2007769726 @default.
- W2000947329 cites W2007825638 @default.
- W2000947329 cites W2008906325 @default.
- W2000947329 cites W2009774571 @default.
- W2000947329 cites W2010064285 @default.
- W2000947329 cites W2010716250 @default.
- W2000947329 cites W2012467294 @default.
- W2000947329 cites W2012808111 @default.
- W2000947329 cites W2012930217 @default.
- W2000947329 cites W2013799054 @default.
- W2000947329 cites W2014020993 @default.
- W2000947329 cites W2014091184 @default.
- W2000947329 cites W2014912931 @default.